281 related articles for article (PubMed ID: 17351368)
21. PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.
Funk M; Endler G; Exner M; Marculescu R; Endler L; Abrahamian H; Mauler H; Grimm A; Raith M; Mannhalter C; Prager R; Irsigler K; Wagner OF
Wien Klin Wochenschr; 2005 Oct; 117(19-20):707-10. PubMed ID: 16416371
[TBL] [Abstract][Full Text] [Related]
22. Plasma PAI-1 levels in obese children--effect of weight loss and influence of PAI-1 promoter 4G/5G genotype.
Estellés A; Dalmau J; Falcó C; Berbel O; Castelló R; España F; Aznar J
Thromb Haemost; 2001 Aug; 86(2):647-52. PubMed ID: 11522017
[TBL] [Abstract][Full Text] [Related]
23. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
Saidi S; Slamia LB; Mahjoub T; Ammou SB; Almawi WY
J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411
[TBL] [Abstract][Full Text] [Related]
24. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
Appel SJ; Harrell JS; Davenport ML
J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
[TBL] [Abstract][Full Text] [Related]
25. [Association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion].
Guan LX; Du XY; Wang JX; Gao L; Wang RL; Li HB; Wang SX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):330-3. PubMed ID: 15952129
[TBL] [Abstract][Full Text] [Related]
26. Influence of the 4G/5G PAI-1 genotype on angiotensin II-stimulated human endothelial cells and in patients with hypertension.
Roncal C; Orbe J; Rodriguez JA; Belzunce M; Beloqui O; Diez J; Páramo JA
Cardiovasc Res; 2004 Jul; 63(1):176-85. PubMed ID: 15194475
[TBL] [Abstract][Full Text] [Related]
27. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
Castelló R; España F; Vázquez C; Fuster C; Almenar SM; Aznar J; Estellés A
Thromb Res; 2006; 117(5):487-92. PubMed ID: 15907980
[TBL] [Abstract][Full Text] [Related]
28. Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.
Eroglu A; Ulu A; Cam R; Akar N
J BUON; 2006; 11(4):481-4. PubMed ID: 17309181
[TBL] [Abstract][Full Text] [Related]
29. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients.
Ezzidi I; Mtiraoui N; Chaieb M; Kacem M; Mahjoub T; Almawi WY
Diabetes Metab; 2009 Jun; 35(3):214-9. PubMed ID: 19419896
[TBL] [Abstract][Full Text] [Related]
30. [Association of PAI-1 gene polymorphism with prognosis of coronary artery disease].
Zhang AY; Ji XW; Guan LX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):233-5. PubMed ID: 18393255
[TBL] [Abstract][Full Text] [Related]
31. The common -675 4G/5G polymorphism in the plasminogen activator inhibitor -1 gene is strongly associated with obesity.
Hoffstedt J; Andersson IL; Persson L; Isaksson B; Arner P
Diabetologia; 2002 Apr; 45(4):584-7. PubMed ID: 12032637
[TBL] [Abstract][Full Text] [Related]
32. Association of plasminogen activator inhibitor-1 4G/5G gene polymorphism with variations in the LDL particle size in healthy Japanese men.
Kitamura Y; Okumura K; Imamura A; Mizuno T; Tsuzuki M; Numaguchi Y; Matsui H; Murohara T
Clin Chim Acta; 2004 Sep; 347(1-2):209-16. PubMed ID: 15313160
[TBL] [Abstract][Full Text] [Related]
33. A-G-4G haplotype of PAI-1 gene polymorphisms -844 G/A, HindIII G/C, and -675 4G/5G is associated with increased risk of ischemic stroke caused by small vessel disease.
Adamski MG; Turaj W; Slowik A; Wloch-Kopec D; Wolkow P; Szczudlik A
Acta Neurol Scand; 2009 Aug; 120(2):94-100. PubMed ID: 19154538
[TBL] [Abstract][Full Text] [Related]
34. Association of ENPP1 (PC-1) K121Q polymorphism with obesity-related parameters in subjects with metabolic syndrome.
González-Sánchez JL; Zabena C; Martínez-Larrad MT; Martínez-Calatrava MJ; Pérez-Barba M; Serrano-Ríos M
Clin Endocrinol (Oxf); 2008 May; 68(5):724-9. PubMed ID: 17986276
[TBL] [Abstract][Full Text] [Related]
35. Age-related increase of pulse pressure and plasminogen activator inhibitor-1 I/D gene polymorphism in essential hypertension.
Mourad JJ; du Cailar G; Nazal EM; Safar ME; Mimran A
J Intern Med; 2005 Jan; 257(1):93-9. PubMed ID: 15606380
[TBL] [Abstract][Full Text] [Related]
36. Plasminogen activator inhibitor-1 polymorphism (4G/5G) predicts recurrence in nonhyperlipidemic postinfarction patients.
Corsetti JP; Ryan D; Moss AJ; Rainwater DL; Zareba W; Sparks CE
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):548-54. PubMed ID: 18096824
[TBL] [Abstract][Full Text] [Related]
37. Role of gender and genetic variance in plasminogen activator inhibitor-1 secretion from human adipose tissue.
van Harmelen V; Wahrenberg H; Eriksson P; Arner P
Thromb Haemost; 2000 Feb; 83(2):304-8. PubMed ID: 10739390
[TBL] [Abstract][Full Text] [Related]
38. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
Emingil G; Berdeli A; Gürkan A; Han Saygan B; Köse T; Atilla G
J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155
[TBL] [Abstract][Full Text] [Related]
39. Genotype and allele frequency of PAI-1 promoter polymorphism in healthy subjects from the west of Mexico. Association with biochemical and hematological parameters.
Ruiz-Quezada S; Vázquez-Del Mercado M; Parra-Rojas I; Rangel-Villalobos H; Best-Aguilera C; Sánchez-Orozco LV; Muñoz-Valle JF
Ann Genet; 2004; 47(2):155-62. PubMed ID: 15183748
[TBL] [Abstract][Full Text] [Related]
40. Plasminogen activator inhibitor 1 expression in platelets is not influenced by the 4G/5G promoter polymorphism.
Brogren H; Wallmark K; Jern S; Karlsson L
Thromb Res; 2008; 121(6):793-7. PubMed ID: 17884148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]